建立国家边境防疫安全屏障

更新于 2026年11月17日 版权声明
六、建立国家边境防疫安全屏障

强化国家边境防疫安全理念,加强风险管理,建立国家边境防疫安全屏障,加强对口岸动物及入境人员的检疫工作,严防国外染病动物及人间病例输入我国。

(赵 华)

参考文献

[1]Wright D,Kortekaas J,Bowden TA,et al.Rift Valley fever:biology and epidemiology[J].J Gen Virol.2019; 100:1187-1199.

[2]Walker PJ,Siddell SG,Lefkowitz EJ,et al.Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019)[J].Arch Virol,2019,164:2417-2429.

[3]Freiberg AN,Sherman MB,Morais MC,et al.Three-dimensional organization of Rift Valley fever virus revealed by cryoelectron tomography[J].J Virol.2008;82:10341-10348.

[4]Piper ME,Sorenson DR,Gerrard SR.Efficient cellular release of Rift Valley fever virus requires genomic RNA[J].PLoS One,2011,6:0018070.

[5]Zamoto-Niikura A,Terasaki K,Ikegami T,et al.Rift valley fever virus L protein forms a biologically active oligomer[J].J Virol,2009,83:12779-12789.

[6]Walter CT,Barr JN.Recent advances in the molecular and cellular biology of bunyaviruses[J].J Gen Virol,2011,92:2467-2484.

[7]Carnec X,Ermonval M,Kreher F,et al.Role of the cytosolic tails of Rift Valley fever virus envelope glycoproteins in viral morphogenesis[J].Virology,2014,448:1-14.

[8]Gauliard N,Billecocq A,Flick R,et al.Rift Valley fever virus noncoding regions of L,M and S segments regulate RNA synthesis[J].Virology,2006,351:170-179.

[9]Ferron F,Li Z,Danek EI,et al.The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes[J].PLoS Pathog,2011,7:12.

[10]Samso A,Bouloy M,Hannoun C.Demonstration of circular ribonucleic acid in the Lumbo virus (Bunyavirus) [J].C R Acad Hebd Seances Acad Sci D,1976,282:1653-1655.

[11]Hartman A.Rift Valley Fever[J].Clin Lab Med,2017,37:285-301.

[12]Gogovi GK,Almsned F,Bracci N,et al.Modeling the Tertiary Structure of the Rift Valley Fever Virus L Protein.Molecules,2019,24.

[13]Lopez N,Muller R,Prehaud C,et al.The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules[J].J Virol,1995,69:3972-3979.

[14]Gaudreault NN,Indran SV,Balaraman V,et al.Molecular aspects of Rift Valley fever virus and the emergence of reassortants[J].Virus Genes.2019,55:1-11.

[15]Paweska JT.Rift Valley fever[J].Rev Sci Tech,2015,34:375-389.

[16]de Boer SM,Kortekaas J,Spel L,et al.Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein[J].J Virol,2012,86:13642-13652.

[17]Pepin M,Bouloy M,Bird BH,et al.Rift Valley fever virus(Bunyaviridae:Phlebovirus) :an update on pathogenesis,molecular epidemiology,vectors,diagnostics and prevention[J].Vet Res,2010,41:2010033.

[18]Gerrard SR,Bird BH,Albario CG,et al.The NSm proteins of Rift Valley fever virus are dispensable for maturation,replication and infection[J].Virology,2007,359:459-465.

[19]Won S,Ikegami T,Peters CJ,et al.NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture[J].J Virol,2006,80:8274-827.

[20]Liu L,Celma CC,Roy P.Rift Valley fever virus structural proteins:expression,characterization and assembly of recombinant proteins[J].Virol J,2008,5:5-82.

[21]Won S,Ikegami T,Peters CJ,et al.NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis[J].J Virol,2007,81:13335-13345.

[22]Terasaki K,Won S,Makino S.The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function[J].J Virol,2013,87:676-682.

[23]Kreher F,Tamietti C,Gommet C,et al.The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts[J].Emerg Microbes Infect,2014,3:1.

[24]Weingartl HM,Zhang S,Marszal P,et al.Rift Valley fever virus incorporates the 78 kDa glycoprotein into virions matured in mosquito C6/36 cells[J].PLoS One,2014:9.

[25]Terasaki K,Makino S.Interplay between the Virus and Host in Rift Valley Fever Pathogenesis[J].J Innate Immun,2015,7:450-458.

[26]Fafetine JM,Tijhaar E,Paweska JT,et al.Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants[J].Vet Microbiol,2007,121:29-38.

[27]Jansen van Vuren P,Potgieter AC,Paweska JT,et al.Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA[J].J Virol Methods,2007,140:106-114.

[28]Phoenix I,Nishiyama S,Lokugamage N,et al.N-Glycans on the rift valley fever virus envelope glycoproteins gn and gc redundantly support viral infection via DC-SIGN[J].Viruses.2016;8.

[29]Mottram TJ,Li P,Dietrich I,et al.Mutational analysis of Rift Valley fever phlebovirus nucleocapsid protein indicates novel conserved,functional amino acids[J].PLoS Negl Trop Dis,2017:11.

[30]Ikegami T,Narayanan K,Won S,et al.Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation[J].PLoS Pathog,2009,5:6.

[31]Ikegami T,Makino S.The pathogenesis of Rift Valley fever[J].Viruses,2011,3:493-519.

[32]Bird BH,Khristova ML,Rollin PE,et al.Complete genome analysis of 33 ecologically and biologically diverse Rift Valley fever virus strains reveals widespread virus movement and low genetic diversity due to recent common ancestry[J].J Virol,2007,81:2805-2816.

[33]Nfon CK,Marszal P,Zhang S,Weingartl HM.Innate immune response to Rift Valley fever virus in goats[J].PLoS Negl Trop Dis,2012,6:24.

[34]Liu J,Sun Y,Shi W,et al.The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages[J].Emerg Microbes Infect,2017,6:136.

[35]Garry CE,Garry RF.Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes)[J] .Theor Biol Med Model,2004,1:1742-4682.

[36]Bouloy M,Weber F.Molecular biology of rift valley Fever virus[J].Open Virol J,2010,4:8-14.

[37]Ikegami T.Molecular biology and genetic diversity of Rift Valley fever virus[J].Antiviral Res,2012,95:293-310.

[38]Evans A,Gakuya F,Paweska JT,et al.Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife[J].Epidemiol Infect,2008,136:1261-1269.

[39]Murithi RM,Munyua P,Ithondeka PM,et al.Rift Valley fever in Kenya:history of epizootics and identification of vulnerable districts[J].Epidemiol Infect,2011,139:372-380.

[40]Gerdes GH.Rift Valley fever[J].Rev Sci Tech,2004,23:613-623.

[41]Linthicum KJ,Britch SC,Anyamba A.Rift Valley Fever:An emerging mosquito-borne disease[J].Annu Rev Entomol,2016,61:395-415.

[42]Pépin M.Rift Valley fever[J].Med Mal Infect,2011,41:322-329.

[43]Brustolin M,Talavera S,Nuez A,et al.Rift Valley fever virus and European mosquitoes:vector competence of Culex pipiens and Stegomyia albopicta[J].Med Vet Entomol,2017,31:365-372.

[44]Davies FG,Highton RB.Possible vectors of Rift Valley fever in Kenya[J].Trans R Soc Trop Med Hyg,1980,74:815-816.

[45]Fontenille D,Traore-Lamizana M,Diallo M,et al.New vectors of Rift Valley fever in West Africa[J].Emerg Infect Dis,1998,4:289-293.

[46]Flick R,Bouloy M.Rift Valley fever virus[J].Curr Mol Med,2005,5:827-834.

[47]Msimang V,Thompson PN,Jansen van Vuren P,et al.Rift valley fever virus exposure amongst farmers,farm workers,and veterinary professionals in central south Africa[J].Viruses,2019:11.

[48]Métras R,Porphyre T,Pfeiffer DU,et al.Exploratory space-time analyses of Rift Valley Fever in South Africa in 2008-2011[J].PLoS Negl Trop Dis,2012,6:28.

[49]Grossi-Soyster EN,Lee J,King CH,et al.The influence of raw milk exposures on Rift Valley fever virus transmission[J].PLoS Negl Trop Dis,2019:13.

[50]Al-Hamdan NA,Panackal AA,Al Bassam TH,et al.The risk of nosocomial transmission of Rift Valley fever[J].PLoS Negl Trop Dis,2015:9.(https://www.daowen.com)

[51]Haneche F,Leparc-Goffart I,Simon F,et al.Rift Valley fever in kidney transplant recipient returning from Mali with viral RNA detected in semen up to four months from symptom onset,France,autumn 2015[J].Euro Surveill,2016,21:1560-7917.

[52]Adam I,Karsany MS.Case report:Rift Valley Fever with vertical transmission in a pregnant Sudanese woman[J].J Med Virol,2008,80:21132.

[53]McMillen CM,Arora N,Boyles DA,et al.Rift Valley fever virus induces fetal demise in Sprague-Dawley rats through direct placental infection[J].Sci Adv,2018:4.

[54]Bird BH,Ksiazek TG,Nichol ST,et al.Rift Valley fever virus[J].J Am Vet Med Assoc,2009,234:883-893.

[55]Rissmann M,Stoek F,Pickin MJ,et al.Mechanisms of inter-epidemic maintenance of Rift Valley fever phlebovirus[J].Antiviral Res,2020,174:21.

[56]Meegan JM,Hoogstraal H,Moussa MI.An epizootic of Rift Valley fever in Egypt in 1977[J].Vet Rec,1979,105:124-125.

[57]McMillen CM,Hartman AL.Rift Valley fever in animals and humans:Current perspectives[J].Antiviral Res,2018,156:29-37.

[58]Jansen van Vuren P,Kgaladi J,Msimang V,et al.Rift Valley Fever Reemergence after 7 Years of Quiescence,South Africa,May 2018.Emerg Infect Dis,2019,25:338-341.

[59]Sabin AB,Blumberg RW.Human infection with Rift Valley fever virus and immunity twelve years after single attack[J].Proc Soc Exp Biol Med,1947,64:385-389.

[60]Grossi-Soyster EN,Banda T,Teng CY,et al.Rift Valley Fever Seroprevalence in Coastal Kenya[J].Am J Trop Med Hyg,2017,97:115-120.

[61]Baudin M,Jumaa AM,Jomma HJE,et al.Association of Rift Valley fever virus infection with miscarriage in Sudanese women:a cross-sectional study[J].Lancet Glob Health,2016,4:e864-e71.

[62]Gray KK,Worthy MN,Juelich TL,et al.Chemotactic and inflammatory responses in the liver and brain are associated with pathogenesis of Rift Valley fever virus infection in the mouse[J].PLoS Negl Trop Dis,2012,6:28.

[63]Boshra H,Lorenzo G,Busquets N,et al.Rift valley fever:recent insights into pathogenesis and prevention[J].J Virol,2011,85:6098-6105.

[64]Shieh WJ,Paddock CD,Lederman E,et al.Pathologic studies on suspect animal and human cases of Rift Valley fever from an outbreak in Eastern Africa,2006-2007[J].Am J Trop Med Hyg,2010,83:38-42.

[65]Reed C,Lin K,Wilhelmsen C,et al.Aerosol exposure to Rift Valley fever virus causes earlier and more severe neuropathology in the murine model,which has important implications for therapeutic development[J].PLoS Negl Trop Dis,2013:7.

[66]Filone CM,Heise M,Doms RW,et al.Development and characterization of a Rift Valley fever virus cell-cell fusion assay using alphavirus replicon vectors[J].Virology,2006,356:155-164.

[67]Ly HJ,Ikegami T.Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins[J].Virol J,2016,13:016-0573.

[68]Billecocq A,Spiegel M,Vialat P,et al.NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription[J].J Virol,2004,78:9798-9806.

[69]Le May N,Dubaele S,Proietti De Santis L,TFIIH transcription factor,a target for the Rift Valley hemorrhagic fever virus[J].Cell,2004,116:541-550.

[70]Iben S,Tschochner H,Bier M,et al.TFIIH plays an essential role in RNA polymerase I transcription[J].Cell,2002,109:297-306.

[71]Le May N,Mansuroglu Z,Léger P,et al.A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells[J].PLoS Pathog,2008,4:0040013.

[72]Crabtree MB,Kent Crockett RJ,Bird BH,et al.Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes:potential role for NSm in mosquito infection[J].PLoS Negl Trop Dis,2012,6:1.

[73]Mansuroglu Z,Josse T,Gilleron J,et al.Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell,inducing chromosome cohesion and segregation defects[J].J Virol,2010;84:928-939.

[74]Struthers JK,Swanepoel R.Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells[J].J Gen Virol,1982,60:381-384.

[75]Bird BH,Albario CG,Nichol ST.Rift Valley fever virus lacking NSm proteins retains high virulence in vivo and may provide a model of human delayed onset neurologic disease[J].Virology,2007,362:10-15.

[76]Kading RC,Crabtree MB,Bird BH,et al.Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes[J].PLoS Negl Trop Dis,2014:8.

[77]Pollitt E,Zhao J,Muscat P,et al.Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NSm is not essential for growth in tissue culture[J].Virology,2006,348:224-232.

[78]Crespo León F,Gutiérrez Díez F,Rodríguez Ferri F,et al.The translation into Spanish of the OIE Manual of diagnostic tests and vaccines for terrestrial animals (mammals,birds and bees) :problems,solutions and conclusions[J].Rev Sci Tech,2005,24:1095-1104.

[79]Swanepoel R,Struthers JK,Erasmus MJ,et al.Comparison of techniques for demonstrating antibodies to Rift Valley fever virus[J].J Hyg,1986,97:317-329.

[80]Caplen H,Peters CJ,Bishop DH.Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development[J].J Gen Virol,1985,66:2271-2277.

[81]Wichgers Schreur PJ,van Keulen L,Kant J,et al.Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy[J].Vaccine,2017,35:3123-3128.

[82]Ragan IK,Davis AS,McVey DS,et al.Evaluation of fluorescence microsphere immunoassay for detection of antibodies to rift valley fever virus nucleocapsid protein and glycoproteins[J].J Clin Microbiol,2018,56:01626-17.

[83]Niklasson B,Peters CJ,Grandien M,et al.Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay[J].J Clin Microbiol,1984,19:225-229.

[84]Paweska JT,Burt FJ,Anthony F,et al.IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants[J].J Virol Methods,2003,113:103-112.

[85]Paweska JT,Jansen van Vuren P,Swanepoel R.Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans[J].J Virol Methods,2007,146:119-124.

[86]Javelle E,Lesueur A,Pommier de Santi V,et al.The challenging management of Rift Valley Fever in humans:literature review of the clinical disease and algorithm proposal[J].Ann Clin Microbiol Antimicrob,2020,19:020-0346.

[87]Williams R,Ellis CE,Smith SJ,et al.Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus[J].J Virol Methods,2011,177:140-146.

[88]Bird BH,Bawiec DA,Ksiazek TG,et al.Highly sensitive and broadly reactive quantitative reverse transcription-PCR assay for high-throughput detection of Rift Valley fever virus[J].J Clin Microbiol,2007,45:3506-3513.

[89]Drosten C,Gttig S,Schilling S,et al.Rapid detection and quantification of RNA of Ebola and Marburg viruses,Lassa virus,Crimean-Congo hemorrhagic fever virus,Rift Valley fever virus,dengue virus,and yellow fever virus by real-time reverse transcription-PCR[J].J Clin Microbiol,2002,40:2323-2330.

[90]Garcia S,Crance JM,Billecocq A,et al.Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds[J].J Clin Microbiol,2001,39:4456-4461.

[91]Jansen van Vuren P,Paweska JT.Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA[J].J Virol Methods,2009,157:15-24.

[92]Escadafal C,Paweska JT,Grobbelaar A,et al.International external quality assessment of molecular detection of Rift Valley fever virus[J].PLoS Negl Trop Dis,2013:7.

[93]Le Roux CA,Kubo T,Grobbelaar AA,et al.Development and evaluation of a realtime reverse transcription-loop-mediated isothermal amplification assay for rapid detection of Rift Valley fever virus in clinical specimens[J].J Clin Microbiol,2009,47:645-651.

[94]Peyrefitte CN,Boubis L,Coudrier D,et al.Real-time reverse-transcription loopmediated isothermal amplification for rapid detection of rift valley Fever virus[J].J Clin Microbiol,2008,46:3653-3659.

[95]Smith MR,Schirtzinger EE,Wilson WC,et al.Rift Valley Fever Virus:Propagation,Quantification,and Storage[J].Curr Protoc Microbiol,2019,55:92.

[96]Anderson GW,Jr,Saluzzo JF,Ksiazek TG,et al.Comparison of in vitro and in vivo systems for propagation of Rift Valley fever virus from clinical specimens[J].Res Virol,1989,140:129-138.

[97]Cêtre-Sossah C,Zeller H,Grandadam M,et al.Genome analysis of Rift Valley fever virus,Mayotte[J].Emerg Infect Dis,2012,18:969-971.

[98]Al-Hazmi A,Al-Rajhi AA,Abboud EB,et al.Ocular complications of Rift Valley fever outbreak in Saudi Arabia[J].Ophthalmology,2005,112:313-318.

[99]Mansfield KL,Banyard AC,McElhinney L,et al.Rift Valley fever virus:A review of diagnosis and vaccination,and implications for emergence in Europe[J].Vaccine,2015,33:5520-5531.

[100]Faburay B,LaBeaud AD,McVey DS,et al.Current Status of Rift Valley Fever Vaccine Development[J].Vaccines,2017:5.

[101]Warimwe GM,Gesharisha J,Carr BV,et al.Chimpanzee adenovirus vaccine provides multispecies protection against Rift Valley fever[J].Sci Rep,2016:6.

[102]Antrobus RD,Coughlan L,Berthoud TK,et al.Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens[J].Mol Ther,2014,22:668-674.

✍AI写作